Role of botulinum toxin A in diplopia following orbital decompression.
Diplopia following orbital decompression is a common complication in Graves' ophthalmopathy. Strabismus surgery is often required to treat the persistent diplopia. The author presents a successful treatment with botulinum toxin A injection in a case of diplopia following orbital decompression. Treatment with botulinum toxin A in the management of new-onset diplopia following orbital decompression has been suggested in a case that is not amenable to prism treatment and may eliminate strabismus surgery in some cases.
Wutthiphan
Sorot
S
Department of Ophthalmology, Priest Hospital, Bangkok, Thailand. sorotw@hotmail.com
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D019299:Decompression, Surgical / Q000009:adverse effects*; D004172:Diplopia / Q000188:drug therapy* / Q000209:etiology*; D004948:Esotropia / Q000000981:diagnostic imaging / Q000209:etiology / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D049970:Graves Ophthalmopathy / Q000601:surgery*; D006801:Humans; D007273:Injections, Intramuscular; D009801:Oculomotor Muscles / Q000187:drug effects; D009915:Orbit / Q000601:surgery*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D019274:Botulinum Toxins, Type A